Owens & Minor (NYSE:OMI) vs. IM Cannabis (NASDAQ:IMCC) Head-To-Head Survey

Owens & Minor (NYSE:OMI) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Owens & Minor and IM Cannabis, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owens & Minor	4	0	3	1	2.13
IM Cannabis	1	0	0	0	1.00

Owens & Minor presently has a consensus target price of $6.35, suggesting a potential upside of 133.03%. Given Owens & Minor’s stronger consensus rating and higher probable upside, equities analysts clearly believe Owens & Minor is more favorable than IM Cannabis.

Profitability

This table compares Owens & Minor and IM Cannabis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Owens & Minor	-13.78%	26.59%	2.45%
IM Cannabis	-9.47%	-134.35%	-11.66%

Earnings & Valuation

This table compares Owens & Minor and IM Cannabis”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owens & Minor	$10.77 billion	0.02	-$362.69 million	($17.40)	-0.16
IM Cannabis	$39.44 million	0.24	-$7.72 million	($0.78)	-2.29

IM Cannabis has lower revenue, but higher earnings than Owens & Minor. IM Cannabis is trading at a lower price-to-earnings ratio than Owens & Minor, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Owens & Minor has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 2.08, meaning that its stock price is 108% more volatile than the S&P 500.

Insider & Institutional Ownership

98.0% of Owens & Minor shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 3.7% of Owens & Minor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Owens & Minor beats IM Cannabis on 10 of the 15 factors compared between the two stocks.

About Owens & Minor

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.